Bridge Pharmaceuticals, Inc.

16 articles about Bridge Pharmaceuticals, Inc.

• Bridge Pharmaceuticals, Inc. Announces Rapid-Turnaround, Flexible-Reporting Occupational Safety Testing Program for Chemical and Pharmaceutical Manufacturers

  11/12/2007

• Bridge Pharmaceuticals, Inc.’s China Lab Gets Accreditation

  8/7/2007

• Bridge Pharmaceuticals, Inc.'s China Facility Receives Full AAALAC Accreditation: First Preclinical CRO with US and China Multispecies Capabilities

  8/6/2007

• Company Profile for Bridge Pharmaceuticals, Inc.

  8/3/2007

• Bridge Pharmaceuticals, Inc. Evolving Quickly

  7/31/2007

• Bridge Pharmaceuticals, Inc. Announces Executive Management Selections: Appointment of CEO, Selection of CSO and Promotion of CFO

  7/30/2007

• James Carignan Has Been Appointed as Vice President, Quality Assurance and Regulatory Compliance for Bridge Pharmaceuticals, Inc. in Beijing, China

  3/1/2007

• Bridge Pharmaceuticals, Inc. Announces Closing Of Its $35 Million Series B Capital Raise To Accelerate Its China And US 'Hybrid' CRO Model

  2/13/2007

• Bridge Pharmaceuticals, Inc. Announces The CRO Industry's First China-US Visiting Scholar Program For Its Employees

  2/1/2007

• Wan Yang Feng, Ph.D. Has Been Appointed Director Of Bioanalytic And Metabolism Of Bridge Pharmaceuticals, Inc.'s Preclinical Laboratory In Beijing

  10/6/2006

• Bridge Pharmaceuticals, Inc. Successfully Validates Beijing Preclinical Laboratory For US Level GLP Compliance

  9/6/2006

• Patrik Sebastian Jeanmonod Has Been Appointed Vice President Finance Of Bridge Pharmaceuticals, Inc.

  6/14/2006

• Bridge Pharmaceuticals, Inc. Announces $22 Million Series B Capital Raise

  6/14/2006

• Bridge Pharmaceuticals, Inc. Takes On China With $22M Series B

  5/30/2006

• Bridge Pharmaceuticals, Inc. Dedicates Its Preclinical Drug Development Laboratory In Beijing

  11/28/2005

• SRI International Announces Taiwan Drug Development Initiative With Bridge Pharmaceuticals, Inc.

  11/7/2005